Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients
Pere Domingo, Maria Karuna Lamarca, José M. Gallego-Escuredo, Ferran Torres, Joan C. Domingo, Joan Villarroya, Ma Del Mar Gutierrez, Ma Gracia Mateo, Francesc Vidal, Francesc Villarroya, Marta Giralt
Profundice en los temas de investigación de 'Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients'. En conjunto forman una huella única.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science